Loading...

ORCHPHARMA Orchid Pharma Ltd Earnings Reports Announcement

rchd

RCHP

Orchid Pharma Ltd

(ORCHPHARMA)

2024 Announcement

Show Summary

Show Summary

Lease Dispute Resolution

Corporate Guarantee Disclosure

Earnings Call Update

USFDA Inspection Report

Compliance Report

Earnings Call Summary

NCLT Meetings Notice

Investor Presentation

Earnings Call Scheduled

Monitoring Report

Merger Announcement

Insolvency Notification

Amalgamation Announcement

Compliance Certificate

Settlement Agreement

Cautionary Letters

Amalgamation Update

Credit Rating Review

GST Order Appeal

USFDA Inspection Success

Earnings Call Update

Investor Call Update

Strong Profit Growth

Monitoring Agency Report

Financial Results Q3

Investor Presentation

Earnings Call Scheduled

Compliance Certificate

Corporate Guarantee Issued

Q2 Earnings Report

Financial Results Published

Earnings Call Update

Strong Q2 Growth

Monitoring Report

Financial Results Q2

Financial Results

Earnings Call Scheduled

Compliance Certificate

Amalgamation Announcement

BSE Warning Letter

NSE Warning Letter

Investor Roadshow

GST Order Update

Q1 FY25 Earnings

Financial Results

Strong Q1 Growth

Earnings Call Audio

Monitoring Agency Report

Q1 Financial Results

Q1 Financial Results

Newspaper Publication

Update on E-Voting Cut-Off ...

Newspaper Publication

Management Changes

Compliance Certificate Subm...

Launch Announcement

Investor Roadshows

Investor Roadshows

Annual Compliance Report Su...

Publication of Audited Fina...

Appointment Approval

Financial Results

Orchid Pharma Q4 Results

Board Meeting Outcome

Monitoring Agency Report

GST Order Disclosure

Compliance Certificate

Compliance Certificate

Submission of Compliance Ce...

Resignation of Director

Explanation for Delay

Investor Roadshow Schedule

Investor Earnings Call

Monitoring Agency Report

Earnings Call Audio Recording

Financial Results

Investor Presentation

Financial Result Announcement

Investor Conferences

Subsidiary Deregistration

Order from GST Department

Approval for Exblifep

Compliance Certificate

Appointment of Company Secr...

Credit Rating Revision

Resignation of Company Secr...

Scheme of Amalgamation and ...

Credit Ratings Update

Investor Conferences

Investor Conferences

Investor Presentation

Monitoring Agency Report

Financial Results Publication

Investor Earning Call

Capacity Expansion

Newspaper Publication

Postal Ballot Process

Appointment of Director

Compliance Certificate

Disclosure of Pending Litig...

Roadshow Intimation

Manufacturing Sublicense Ag...

Financial Statements

Monitoring Agency Report

Financial Statements

Financial Statements

Compliance Certificate

Equity, Joint Ventures

External Links:

Data:

Orchid Pharma reported Q1 FY25 sales of Rs. 244 crores (up 34% from Rs. 182.9 crores last year) and EBITDA of Rs. 41 crores (up 71% from Rs. 24 crores), highlighting its focus on operational efficiency and product launch readiness for Orblicef.

AI Assistant

Orchid Pharma Ltd

2024

Announcement

Find Answers

Ask about any part of the document to get insights, explanations, or key details.